Medicinal Organic Cannabis Australia (MOCA) is orientated around production and cultivation of organic medicinal grade cannabis. We provide medication to authorise prescription holders in alignment with Australian government regulations. Our vision is orientated towards sustainable long-term results.

North American cannabis industry experiencing 30-40% annual growth rates, driven by trend to legalize cannabis for both medicinal and recreational use

It also claimed demand could grow to $300m annually within 10 years if cannabis-derived pharmaceuticals become more mainstream. Morgans Financial claims the much larger US market could be worth around $US21 billion by 2020